Agenda | Speaker |
|---|---|
Welcome and Introduction | Elie Haddad (Montreal, Canada) |
Why Do We Need Artificial Intelligence? | Elie Haddad (Montreal, Canada) |
Artificial Intelligence to Shorten Diagnosis of Patients with Primary Immunodeficiencies and Detect Phenotypic Patterns of Rare Diseases | Manish Butte (Los Angeles, USA) |
Early Detection of Primary Antibody Deficiencies in Primary Care with Screening Algorithms | Helen Leavis (Utrecht, Netherlands) |
Panel Discussion: Ethical, Medical and Regulatory Considerations in Integrating AI into the Clinical Workflow | All |
Closing Remarks | Manish Butte (Los Angeles, USA) |
France18/10/2024
ESID 2024
Octapharma Symposium
Artificial Intelligence to Transform Diagnosis and Care of Patients with Immunodeficiencies
Friday, October 18, 2024
12:15 - 13:45 CET
Plenary Hall | Marseille Chanot Palais des Congrès, France
Primary immunodeficiencies are usually rare and present with a wide variety of symptoms. This situation often results in substantial delays in diagnosis and treatment, which in turn aggravate both mortality and morbidity.
Recently, developments in the field of artificial intelligence (AI) applied to health care have demonstrated the potential to transform and expedite diagnosis as well as care of patients with primary immunodeficiencies.
The present symposium will explore these latest scientific advances and practical applications in a way most meaningful for non-AI specialists. The panel of experts will guide the audience through the methodologies which were employed to improve outcomes. In addition, results will be put into perspective by considering ethical, medical and regulatory aspects required to integrate AI into the clinical workflow.
This interactive session will share valuable practical insights and exchange views while questions and comments from the audience will be encouraged by the faculty to broaden the debate.
Symposium programme
Chairs: Elie Haddad & Manish Butte
This scientific information may include data/information on investigational uses of compounds/drugs that have not yet been approved by regulatory authorities. This program was developed for use outside the U.S., is intended for non-U.S. HCPs, and is to be used in accordance with local laws and regulations.
Meet the speakers
Elie Haddad
Sainte-Justine University Hospital
Montreal, Canada
Manish Butte
UCLA
Los Angeles, USA
Helen Leavis
University Medical Centre Utrecht,
Utrecht, Netherlands
To attend this symposium, please register to the ESID 2024 Congress.
Available on-demand on Science Hub
Can’t join us in Marseille? Watch the symposium on-demand on Science Hub, exclusively for healthcare professionals.